Table 1.
Clinical characteristics of the cancer patients
| Af group (n = 753) | Non-Af group (n = 17 464) | Total (n = 18 217) | |
|---|---|---|---|
| Age, years | 72 [66–78] | 65 [54–73] | 65 [55–73] |
| Male (%) | 543 (72) | 8805 (50) | 9348 (51) |
| Stage of cancer | |||
| Non-advanced (%) (0, I, and II) | 500 (69) | 11548 (69) | 12048 (69) |
| Advanced (%) (III and IV) | 222 (31) | 5136 (31) | 5358 (31) |
| Hypertension (%) | 416 (55) | 3953 (23) | 4369 (24) |
| Dyslipidaemia (%) | 239 (32) | 2517 (14) | 2756 (15) |
| Diabetes mellitus (%) | 315 (42) | 3422 (20) | 3737 (21) |
| Smoking (%) | 220 (37) | 3791 (32) | 4011 (33) |
| Drinking history (%) | 130 (17) | 1315 (8) | 1445 (8) |
| BMI | 22.9 [20.4–24.9] | 22.2 [20.0–24.4] | 22.2 [20.0–24.5] |
| WBCs, ×103/µl | 6.2 [5.0–7.7] | 6.2 [5.0–7.7] | 6.2 [5.0–7.7] |
| Neutrophils, ×103/µl | 3.9 [3.0–5.2] | 3.9 [2.9–5.1] | 3.9 [2.9–5.1] |
| Lymphocytes, ×103/µl | 1.5 [1.2–2.0] | 1.6 [1.2–2.0] | 1.6 [1.2–2.0] |
| NLR | 2.5 [1.8–3.7] | 2.4 [1.7–3.5] | 2.4 [1.7–3.5] |
| CRP, mg/dl | 0.23 [0.08–0.91] | 0.18 [0.07–0.84] | 0.18 [0.07–0.84] |
| Alb, mg/dl | 3.9 [3.6–4.2] | 4 [3.6–4.3] | 4 [3.6–4.3] |
| Hb, g/dl | 13.2 [11.7–14.4] | 13.2 [12–14.2] | 13.2 [12–14.2] |
Data are given as median [interquartile range] or number (percentage).
Af, atrial fibrillation; Alb, albumin; BMI, body mass index; CRP, C-reactive protein; Hb, haemoglobin; NLR, neutrophil-to-lymphocyte ratio; WBC, white blood cell.